Institutional Manager · CIK 0001609251
Krensavage Asset Management, LLC
NEW YORK, NY · File #028-16807
Latest AUM
$283,112
Positions
18
Top-10 Concentration
87.1%
Filings
10
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| ADD | ENANTA PHARMACEUTICALS INC | ENTA | +651,946 | +$10,281 | +$8,035 |
| REDUCE | GSK PLC-SPON ADR | GLAXF | -175,000 | -$8,583 | +$1,599 |
| ADD | BIOMARIN PHARMACEUTICAL INC | BMRN | +119,336 | +$7,092 | +$2,137 |
| NEW | ULTRAGENYX PHARMACEUTICAL IN | RARE | +149,634 | +$3,442 | $0 |
| REDUCE | UNITED THERAPEUTICS CORP | UTHR | -6,364 | -$3,101 | +$6,644 |
| REDUCE | ALKERMES PLC | ALKS | -100,000 | -$2,798 | -$420 |
| REDUCE | SUPERNUS PHARMACEUTICALS INC | SUPN | -49,980 | -$2,484 | +$694 |
| REDUCE | AVADEL PHARMACEUTICALS | G29687103 | -100,000 | -$2,155 | +$6,003 |
| ADD | BIONTECH SE-ADR | BNTX | +20,157 | +$1,919 | -$271 |
| REDUCE | EXELIXIS INC | EXEL | -25,000 | -$1,096 | +$1,312 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202518 pos · $283,112
- 13F HOLDINGS REPORTQ/E Sep 202517 pos · $234,698
- 13F HOLDINGS REPORTQ/E Jun 202515 pos · $188,935
- 13F HOLDINGS REPORTQ/E Mar 202514 pos · $180,885
- 13F HOLDINGS REPORT (Amended)Q/E Dec 202412 pos · $169,025
- 13F HOLDINGS REPORTQ/E Dec 202412 pos · $169,025
- 13F HOLDINGS REPORTQ/E Sep 202413 pos · $178,461
- 13F HOLDINGS REPORTQ/E Jun 202413 pos · $217,801
- 13F HOLDINGS REPORTQ/E Mar 202412 pos · $225,525
- 13F HOLDINGS REPORTQ/E Dec 202312 pos · $271,606
Top 18 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | UNITED THERAPEUTICS CORP | UTHR | 91,282 | $44,477 | 15.71% |
| 2 | ENANTA PHARMACEUTICALS INC | ENTA | 2,766,390 | $43,626 | 15.41% |
| 3 | BIOMARIN PHARMACEUTICAL INC | BMRN | 524,786 | $31,188 | 11.02% |
| 4 | JAZZ PHARMACEUTICALS PLC | JAZZ | 167,816 | $28,529 | 10.08% |
| 5 | EXELIXIS INC | EXEL | 493,526 | $21,631 | 7.64% |
| 6 | AVADEL PHARMACEUTICALS | G29687103 | 855,860 | $18,444 | 6.51% |
| 7 | SANOFI-ADR | SNYNF | 323,946 | $15,698 | 5.54% |
| 8 | SUPERNUS PHARMACEUTICALS INC | SUPN | 313,499 | $15,581 | 5.50% |
| 9 | CARDINAL HEALTH INC | CAH | 73,745 | $15,155 | 5.35% |
| 10 | INDIVIOR PLC | INDV | 339,532 | $12,182 | 4.30% |
| 11 | VANDA PHARMACEUTICALS INC | VNDA | 1,180,388 | $10,411 | 3.68% |
| 12 | BIONTECH SE-ADR | BNTX | 99,523 | $9,475 | 3.35% |
| 13 | GSK PLC-SPON ADR | GLAXF | 96,729 | $4,744 | 1.68% |
| 14 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 149,634 | $3,442 | 1.22% |
| 15 | REGENERON PHARMACEUTICALS | REGN | 4,000 | $3,087 | 1.09% |
| 16 | ALKERMES PLC | ALKS | 107,822 | $3,017 | 1.07% |
| 17 | BIOGEN INC | BIIB | 10,000 | $1,760 | 0.62% |
| 18 | EVOLUS INC | EOLS | 100,000 | $665 | 0.23% |